Table 4: Effects of POMx supplementation on safety parameters1.

VariablesHealthy controls ( )T2DM subjects ( )
ScreenWeek 4ScreenWeek 4

Aspartate aminotransferase (U/L)
Alanine aminotransferase (U/L)
Alkaline phosphatase (U/L)
Bilirubin, total (mg/dL)
Total protein (g/dL)
Albumin (g/dL)
Globulin (g/dL)
Albumin/globulin ratio
Sodium (mEq/L)
Potassium (mEq/L)
Chloride (mEq/L)
Calcium (mg/dL)
Thyroxine (T4) (ug/dL)
T3 Uptake (%)
Blood urea nitrogen (mg/dL)
Creatinine (mg/dL)
Blood urea nitrogen/creatinine ratio 2
White blood cell (K/mm3)
Red blood cell (M/mm3)
Hemoglobin (gm/dL)
Hematocrit (%)
Platelet count (K/mm3)

Data are mean ± SD.
Significantly different from baseline ( ); T2DM: type 2 diabetes mellitus.